-
Garlic Extract Targets Acute Myeloid Leukemia Cells
29 Oct 2025 10:40 GMT
… Acute Myeloid Leukemia
In the relentless pursuit of effective therapies for acute myeloid leukemia … extract in combating acute myeloid leukemia by directly targeting … : AI Generated
Tags: acute myeloid leukemia researchAllium sativum health benefitscancer …
-
<![CDATA[FDA Approves Revumenib for Relapsed/Refractory NPM1-Mutant Acute Myeloid Leukemia]]>
24 Oct 2025 22:54 GMT
… for relapsed or refractory acute myeloid leukemia with a susceptible NPM1 … -revumenib-relapsed-or-refractory-acute-myeloid-leukemia-susceptible-npm1-mutation
Syndax … in relapsed or refractory mNPM1 acute myeloid leukemia. News release. Syndax Pharmaceuticals …
-
FDA approves revumenib for relapsed or refractory acute myeloid leukemia with a susceptible NPM1 mutation
24 Oct 2025 20:08 GMT
… inhibitor, for relapsed or refractory acute myeloid leukemia with a susceptible nucleophosmin 1 …
-
Syndax Announces FDA Approval of Revuforj® (revumenib) in Adult and Pediatric Patients with Relapsed or Refractory NPM1 Mutated Acute Myeloid Leukemia
24 Oct 2025 17:58 GMT
… NPM1-mutated relapsed or refractory acute myeloid leukemia: the AUGMENT-101 study. … ) Nucleophosmin 1–Mutated (NPM1m) Acute Myeloid Leukemia (AML): Updated Results from the … in Oncology (NCCN Guidelines®) for Acute Myeloid Leukemia (Version 1.2026 – September …
-
Moleculin Expands Global IP Portfolio with New Australian Patent for Annamycin
29 Oct 2025 12:35 GMT
… developed for the treatment of acute myeloid leukemia (AML) and soft tissue … treatment of relapsed or refractory acute myeloid leukemia (AML) and soft tissue … treatment of relapsed or refractory acute myeloid leukemia. Following a successful Phase 1B …
-
Nanostructured Chemotherapy Delivery Shows 20,000x Effectiveness in AML
29 Oct 2025 15:37 GMT
… a small animal model of acute myeloid leukemia (AML), a fast-moving, difficult …
-
IN8bio Expands INB-100 Phase 1 Clinical Trial with Addition of The Ohio State University as New Site
29 Oct 2025 12:00 GMT
… , INB-100, is focused on acute myeloid leukemia evaluating haplo-matched allogeneic γδ T …
-
<![CDATA[Combination Therapies in AML Treatment Approach]]>
28 Oct 2025 20:46 GMT
Patients with acute myeloid leukemia (AML) have access to increasingly …
-
<![CDATA[Tracking the Shifting Treatment Landscape of AML]]>
28 Oct 2025 20:46 GMT
Patients with acute myeloid leukemia (AML) have witnessed a dramatic …
-
Suleika Jaouad Reflects, 15 Years After Her Leukemia Diagnosis
27 Oct 2025 20:00 GMT
… first presented with symptoms of acute myeloid leukemia at 22, you were misdiagnosed … of myelodysplastic syndrome and later acute myeloid leukemia. But it was my first …
About
© 1995-2025